Combination effective for the treatment of impotence
This invention relates to the treatment of impotence comprising co-administering (1) a potassium channel opener and (2) a compound which elevates cyclic guanosine 3′,5′-monophosphate (cGMP) levels. The combination is particularly suitable for the treatment of patients suffering from impotence or ere...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This invention relates to the treatment of impotence comprising co-administering (1) a potassium channel opener and (2) a compound which elevates cyclic guanosine 3′,5′-monophosphate (cGMP) levels. The combination is particularly suitable for the treatment of patients suffering from impotence or erectile dysfunction.
This invention relates to the treatment of erectile dysfunction with a combination of (1) a compound selected from potassium channel openers, and (2) a compound selected from compounds which elevate cGMP levels. Sildenafil or a pharmaceutically acceptable salt thereof is preferred as the cGMP PDE elevator. Also included are compositions and kits comprising such impotence treating compounds. |
---|